Clinical Trial Update: Cryoablation Combined With Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating cryoablation with camrelizumab and apatinib in advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• Cryoablation

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN